We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$3.25B
AUM Growth
+$358M
Cap. Flow
+$138M
Cap. Flow %
4.23%
Top 10 Hldgs %
63.35%
Holding
3,391
New
290
Increased
1,484
Reduced
798
Closed
229

Sector Composition

Rank Sector Weight
1 Technology 8.07%
2 Consumer Discretionary 4.3%
3 Financials 3.96%
4 Healthcare 3.29%
5 Consumer Staples 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRSU
3026
Pursuit Attractions and Hospitality Inc
PRSU
$1.4B
$1K ﹤0.01%
+26
New +$1.19K
JBTM
3027
JBT Marel
JBTM
$7.41B
$1K ﹤0.01%
8
CDMO
3028
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1K ﹤0.01%
+33
New +$944
ASAI
3029
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$1K ﹤0.01%
111
GRTS
3030
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1K ﹤0.01%
84
+16
+24% +$177
CHUY
3031
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$1K ﹤0.01%
+41
New +$1.25K
GHSI
3032
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$1K ﹤0.01%
20
HA
3033
DELISTED
Hawaiian Holdings, Inc.
HA
$1K ﹤0.01%
35
-50
-59% -$1.01K
SILK
3034
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1K ﹤0.01%
33
+6
+22% +$300
CBH
3035
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$1K ﹤0.01%
113
+2
+2% +$21
CONN
3036
DELISTED
Conn's Inc.
CONN
$1K ﹤0.01%
+63
New +$1.42K
FUSN
3037
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1K ﹤0.01%
300
DOOR
3038
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$1K ﹤0.01%
+11
New +$1.26K
NGMS
3039
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$1K ﹤0.01%
22
-139
-86% -$4.82K
KRTX
3040
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1K ﹤0.01%
7
FAZE
3041
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$1K ﹤0.01%
+50
New +$510
NSTG
3042
DELISTED
NanoString Technologies, Inc.
NSTG
$1K ﹤0.01%
+24
New +$1.05K
DMK
3043
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$1K ﹤0.01%
12
HT
3044
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$1K ﹤0.01%
+61
New +$576
SCU
3045
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$1K ﹤0.01%
29
-74
-72% -$1.69K
NXGN
3046
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1K ﹤0.01%
+66
New +$1.06K
WE
3047
DELISTED
WeWork Inc.
WE
$1K ﹤0.01%
+3
New +$1.1K
DRTT
3048
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
$1K ﹤0.01%
500
AMRS
3049
DELISTED
Amyris Inc.
AMRS
$1K ﹤0.01%
150
-141
-48% -$1.32K
MTEM
3050
DELISTED
Molecular Templates, Inc.
MTEM
$1K ﹤0.01%
20

Similar funds

SignatureFD's Q4 2021 Portfolio in Review

As of Q4 2021, SignatureFD held 3,391 positions worth $3.25B, up 12% from $2.89B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

SignatureFD deployed $138M of net new capital in Q4 2021, opening 290 new positions and adding to 1,484 existing holdings. Its largest new stake was Invesco DB US Dollar Index Bearish Fund: 40,000 shares worth $810K.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.8% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $9.57M trimmed.

  • SignatureFD's largest Q4 2021 buy was Invesco DB US Dollar Index Bearish Fund: 40,000 shares worth $810K.
  • SignatureFD added most to iShares Core MSCI EAFE ETF in Q4 2021, an estimated $24.3M increase.
  • SignatureFD's biggest Q4 2021 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $9.57M.
  • SignatureFD fully exited iShares ESG Aware US Aggregate Bond ETF in Q4 2021, selling an estimated $877K.
  • SignatureFD's ten largest holdings make up 63% of its $3.25B portfolio in Q4 2021.
  • SignatureFD opened 290 new positions and closed 229 in Q4 2021.
  • SignatureFD's portfolio value rose 12% quarter-over-quarter to $3.25B.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.